Slide 1: First Quarter Figures 2025
First Quarter Figures 2025 Analyst presentation Investor Relations 29.04.2025
Slide 2: Disclaimer
2 First Quarter Figures 2025 Investor Relations, 29.04.2025 Disclaimer This presentation contains certain statements that are the Company’s ability to continue to receive adequate neither reported financial results nor other historical products from its vendors on acceptable terms, or at all, and in
Slide 3: Group performance
CLARIANT™ Z Group performanc j
Slide 4: Highlights Q1 2025 Key messages
4 First Quarter Figures 2025 Investor Relations, 29.04.2025 Highlights Q1 2025 Key messages Key Figures in CHF – Further improved profitability in challenging environment ▪ Sales up 1 % in LC and flat in CHF – positive pricing (+ 1 %) and scope (+ 2 %) compensated for slightly lower volumes (- 2 %)
Slide 5: Q1 sales: 1% LC growth – positive pricing and growth in CC and AA
5 First Quarter Figures 2025 Investor Relations, 29.04.2025 Q1 sales: 1 % LC1 growth – positive pricing and growth in CC (incl. LMC) and AA compensated for expected lower CA2 volumes +1% -1% 1 014 1 026 1 013 5 - 18 25 -5 -8 +1% -2% +2% flat -1% Care Chemicals Care Chemicals Positive Net impact on M
Slide 6: Q1 EBITDA b.e.i: 70 bps margin improvement driven by CC and CA
6 First Quarter Figures 2025 Investor Relations, 29.04.2025 Q1 EBITDA b.e.i:1 70 bps margin improvement driven by CC and CA with AA2 flat; reported margin impacted by restructuring CHF 38 m restructuring: (YoY ∆) - CC CHF 12 m (- 12 m) +3% - CA CHF 4 m (- 5 m) - AA CHF 10 m (- 1 m) + 70 bps - Corpor
Slide 7: Business performance
Business performance
Slide 8: First Quarter 2025 Highlights Care Chemicals
8 First Quarter Figures 2025 Investor Relations, 29.04.2025 First Quarter 2025 Highlights Care Chemicals in CHF m Q1 2025 Q1 2024 % CHF % LC1 – Volume organically up 1 % due to continued recovery in Sales 599 581 3 6 Crop Solutions and good aviation season (North America) EBITDA 117 123 -5 compensat
Slide 9: First Quarter 2025 Highlights Catalysts
9 First Quarter Figures 2025 Investor Relations, 29.04.2025 First Quarter 2025 Highlights Catalysts in CHF m Q1 2025 Q1 2024 % CHF % LC1 – Expected soft start in 2025 after very strong Q4 2024, Sales 162 187 - 13 - 13 economic environment remains weak, and utilization rates EBITDA 23 25 -8 continue
Slide 10: First Quarter 2025 Highlights Adsorbents & Additives
10 First Quarter Figures 2025 Investor Relations, 29.04.2025 First Quarter 2025 Highlights Adsorbents & Additives in CHF m Q1 2025 Q1 2024 % CHF % LC1 – Volume increased due to growth in Additives with Polymer Sales 252 246 2 2 Solutions (> 10 %) and Coatings & Adhesives (> 10 %); EBITDA 37 36 3 low
Slide 11: Completion of CHF 175 m performance programs; Investor Day 2024 savings program
11 First Quarter Figures 2025 Investor Relations, 29.04.2025 Completion of CHF 175 m Investor Day 2024 savings program performance programs set to deliver CHF 80 m by 2027 175 Q1: CHF 3 m Run-rate savings of CHF 80 m through BU and Corporate actions by 2027 with significant contribution already in 2
Slide 12: Outlook
Outlook ~ Greater chemistry
Slide 13: Outlook: Current assessment of tariffs shows manageable direct impacts
13 First Quarter Figures 2025 Investor Relations, 29.04.2025 Outlook: Current assessment of tariffs shows manageable direct impacts due to global footprint and local-for-local strategy Region Local Local Raw Material ➔ Current assessment of tariffs shows manageable Production Sourcing direct impacts
Slide 14: Outlook confirmed under current conditions: 2025 modest top-line growth and margin improvement
14 First Quarter Figures 2025 Investor Relations, 29.04.2025 Outlook confirmed under current conditions: 2025 modest top-line growth and further margin improvement 2025 External Factors Internal Factors – Moderate slowdown in global GDP, – Tariffs task force established to assess Top line reduced in
Slide 15: Appendix
CLARIANT™
Slide 16: Modeling Guidance FY 2025 versus FY 2024
16 First Quarter Figures 2025 Investor Relations, 29.04.2025 Modeling Guidance FY 2025 versus FY 2024 – under current conditions • CHF 25 sales impact (actual Q1) Acquisition • On-track profitability with acquisition business case Lucas Meyer Cosmetics • Scope effect in Q1 2025 for Care Chemicals du
Slide 17: First Quarter 2025 – Overview
17 First Quarter Figures 2025 Investor Relations, 29.04.2025 First Quarter 2025 – Overview Group Care Chemicals in CHF m Q1 2025 Q1 2024 % CHF % LC1 in CHF m Q1 2025 Q1 2024 % CHF % LC1 Sales 1 013 1 014 0 1 Sales 599 581 3 6 EBITDA 152 173 - 12 EBITDA 117 123 -5 EBITDA margin 15.0 % 17.1 % EBITDA m
Slide 18: Geographic split Regional headline
18 First Quarter Figures 2025 Investor Relations, 29.04.2025 Geographic split Regional headline Q1 sales CHF 1 013 m – EMEA sales up 6 %, driven by volumes and scope with in CHF m, % in local currency1 flat pricing. Care Chemicals with increased volumes and additional scope while pricing slightly do
Slide 19: Cost dynamics – year on year and sequentially
19 First Quarter Figures 2025 Investor Relations, 29.04.2025 Cost dynamics – year on year and Q1 2025: Pricing slightly up and sequentially slightly up volumes slightly down (Catalysts) − Raw materials in Q1 increased (year on year and sequential 1 %) − Uncertain economic environment maintained in Q
Slide 20: Exposure to attractive consumer markets, with accelerating demand for sustainable products
20 First Quarter Figures 2025 Investor Relations, 29.04.2025 Exposure to attractive consumer markets of close to 50 %... …with accelerating demand for sustainable products Sales by End Market 2021 (Total Group) Sales by End Market Q1 LTM 20251 Chemical Chemical Process Process Consumer (Catalysts) (
Slide 21: ESG – Clariant's Sustainability Transformation Commitment
21 First Quarter Figures 2025 Investor Relations, 29.04.2025 ESG – Clariant’s Sustainability Transformation Commitment Sustainability priorities Investment in operations and portfolio Fighting Climate Change Increasing Circularity Sustainable operations Reducing our own carbon Products and solutions
Slide 22: Significant improvement of non-financial KPIs
22 First Quarter Figures 2025 Investor Relations, 29.04.2025 Significant improvement of non-financial KPIs – Fully on track to deliver updated 2030 greenhouse gas (GHG) targets Reducing corporate GHG emissions New operating model driving customer satisfaction and 46.9 % reduction employee engagement
Slide 23: Clariant's Leading Sustainability Ratings and Rankings
23 First Quarter Figures 2025 Investor Relations, 29.04.2025 Clariant’s Leading Sustainability Ratings and Rankings Status as of March 2025 Index / Ranking / Clariant Score / Percentile First Year of Status / Comments Rating Rank or Range Inclusion 32% 12% 14% 17% 7% 8% 10% AA / Range: AAA to CCC Se
Slide 24: Calendar of Upcoming Corporate Events
24 First Quarter Figures 2025 Investor Relations, 29.04.2025 Calendar of Upcoming Corporate Events 29 April 2025 30 October 2025 First Quarter Third Quarter / 2025 Reporting Nine Month 2025 Reporting 31 July 2025 26 February 2026 Second Quarter / Fourth Quarter / Half Year 2025 Full Year 2025 Report
Slide 25: The Executive Leadership Team
25 First Quarter Figures 2025 Investor Relations, 29.04.2025 The Executive Leadership Team Conrad Keijzer Chief Executive Officer Executive Leadership Team Executive Steering Committee Christian Vang Jens Cuntze Angela Cackovich Bill Collins Tatiana Berardinelli Judith Bischof Richard Haldimann Busi
Slide 26: IR Contacts
26 First Quarter Figures 2025 Investor Relations, 29.04.2025 IR Contacts ANDREAS SCHWARZWÄLDER Head of Investor Relations Phone: +41 61 469 63 73 Email: investor-relations@clariant.com THIJS BOUWENS Investor Relations Officer Phone: +41 61 469 63 73 Email: investor-relations@clariant.com
Slide 27: Thank you
Thank you